{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:50:08Z","timestamp":1781650208763,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CHU Dijon","award":["AOI"],"award-info":[{"award-number":["AOI"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00592-019-01340-7","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T13:04:49Z","timestamp":1555074289000},"page":"749-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CETP activity is not associated with carotid intima-media thickness in patients with poorly controlled type 2 diabetes"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-6714","authenticated-orcid":false,"given":"Benjamin","family":"Bouillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Terriat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lagrost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Verges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"5","key":"1340_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/CIRCULATIONAHA.114.014025","volume":"132","author":"PJ Barter","year":"2015","unstructured":"Barter PJ, Nicholls SJ, Kastelein JJP, Rye K-A (2015) Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular Risk? CETP inhibition as a strategy to reduce cardiovascular risk: the pro case. Circulation 132(5):423\u2013432","journal-title":"Circulation"},{"issue":"3","key":"1340_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/01.ATV.0000118278.21719.17","volume":"24","author":"RW Clark","year":"2004","unstructured":"Clark RW, Sutfin TA, Ruggeri RB et al (2004) Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol 24(3):490\u2013497","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1340_CR3","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.2337\/diabetes.54.12.3554","volume":"54","author":"R Vries de","year":"2005","unstructured":"de Vries R, Perton FG, Dallinga-Thie GM et al (2005) Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes 54(12):3554\u20133559","journal-title":"Diabetes"},{"issue":"12","key":"1340_CR4","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/0026-0495(94)90007-8","volume":"43","author":"J Kahri","year":"1994","unstructured":"Kahri J, Syv\u00e4nne M, Taskinen MR (1994) Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 43(12):1498\u20131502","journal-title":"Metabolism"},{"issue":"8","key":"1340_CR5","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/diabetes.48.8.1631","volume":"48","author":"SC Riemens","year":"1999","unstructured":"Riemens SC, van Tol A, Sluiter WJ, Dullaart RP (1999) Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes 48(8):1631\u20131637","journal-title":"Diabetes"},{"issue":"9","key":"1340_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s001250050791","volume":"40","author":"M Passarelli","year":"1997","unstructured":"Passarelli M, Catanozi S, Nakandakare ER et al (1997) Plasma lipoproteins from patients with poorly controlled diabetes mellitus and\u2009\u00ab\u2009in vitro\u2009\u00bb\u2009glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins. Diabetologia 40(9):1085\u20131093","journal-title":"Diabetologia"},{"issue":"48","key":"1340_CR7","doi-asserted-by":"publisher","first-page":"37504","DOI":"10.1074\/jbc.M007210200","volume":"275","author":"T Gautier","year":"2000","unstructured":"Gautier T, Masson D, de Barros JP et al (2000) Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity. J Biol Chem 275(48):37504\u201337509","journal-title":"J Biol Chem"},{"issue":"20","key":"1340_CR8","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.jacc.2007.06.052","volume":"50","author":"M Zeller","year":"2007","unstructured":"Zeller M, Masson D, Farnier M et al (2007) High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction. J Am Coll Cardiol 50(20):1948\u20131955","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1340_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0009-8981(94)90199-6","volume":"231","author":"V Guyard-Dangremont","year":"1994","unstructured":"Guyard-Dangremont V, Lagrost L, Gambert P, Lallemant C (1994) Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP). Clin Chim Acta Int J Clin Chem 231(2):147\u2013160","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"10","key":"1340_CR10","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2337\/dc14-2732","volume":"38","author":"MW Lorenz","year":"2015","unstructured":"Lorenz MW, Price JF, Robertson C et al (2015) Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. Diabetes Care 38(10):1921\u20131929","journal-title":"Diabetes Care"},{"issue":"9","key":"1340_CR11","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2337\/diacare.23.9.1310","volume":"23","author":"Y Yamasaki","year":"2000","unstructured":"Yamasaki Y, Kodama M, Nishizawa H et al (2000) Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 23(9):1310\u20131315","journal-title":"Diabetes Care"},{"issue":"5","key":"1340_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diab.43.5.634","volume":"43","author":"Y Yamasaki","year":"1994","unstructured":"Yamasaki Y, Kawamori R, Matsushima H et al (1994) Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43(5):634\u2013639","journal-title":"Diabetes"},{"issue":"2","key":"1340_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","volume":"23","author":"PJ Barter","year":"2003","unstructured":"Barter PJ, Brewer HB, Chapman MJ, Hennekens CH, Rader DJ, Tall AR (2003) Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc 23(2):160\u2013167","journal-title":"Arterioscler Thromb Vasc"},{"issue":"2","key":"1340_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1464-5491.2007.02033.x","volume":"24","author":"M Alssema","year":"2007","unstructured":"Alssema M, Dekker JM, Kuivenhoven JA et al (2007) Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study. Diabet Med 24(2):117\u2013123","journal-title":"Diabet Med"},{"issue":"1","key":"1340_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jacl.2017.10.023","volume":"12","author":"T Christen","year":"2018","unstructured":"Christen T, Trompet S, Noordam R et al (2018) Mendelian randomization analysis of cholesteryl ester transfer protein and subclinical atherosclerosis: A population-based study. J Clin Lipidol 12(1):137\u2013144.e1","journal-title":"J Clin Lipidol"},{"key":"1340_CR16","doi-asserted-by":"crossref","unstructured":"Lagrost L (1999) relationship of cholesteryl ester transfer protein to atherosclerosis. In: Plasma Lipids and Their Role in Disease p. 217\u201131. (Advances Vascular Biology; vol. 5)","DOI":"10.4324\/9780203304815_chapter_11"},{"issue":"2","key":"1340_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","volume":"31","author":"MJ Chapman","year":"2010","unstructured":"Chapman MJ, Le Goff W, Guerin M, Kontush A (2010) Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J 31(2):149\u2013164","journal-title":"Eur Heart J"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01340-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T23:24:01Z","timestamp":1586561041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01340-7","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study were in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients before inclusion.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}